OptoDyCE as an automated system for high-throughput all-optical dynamic cardiac electrophysiology

Nature Communications

Volumn 7, Issue , 2016, Pages

  Klimas, Aleksandra ^a   Ambrosi, Christina M ^a   Yu, Jinzhu ^a   Williams, John C ^a   Bien, Harold ^a   Entcheva, Emilia ^a  

^a St Francis Hospital The Heart Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOFETILIDE; NIFEDIPINE; POTASSIUM CHANNEL HERG; CARDIOTOXIN;

CARDIOVASCULAR SYSTEM; CELLS AND CELL COMPONENTS; CELLULAR AUTOMATON; DRUG; HUMAN ACTIVITY; PHENOTYPE; RODENT; THEORETICAL STUDY;

ANALYTIC METHOD; ARTICLE; AUTOMATION; CARDIOTOXICITY; CELL LEVEL; CONTROLLED STUDY; DRUG SCREENING; HEART ELECTROPHYSIOLOGY; HUMAN; HUMAN CELL; OPTICS; OPTODYCE; OPTOGENETICS; SOMATIC CELL; ANIMAL; CARDIAC MUSCLE CELL; CELL CULTURE; DRUG DEVELOPMENT; DRUG EFFECT; EVALUATION STUDY; HEART FUNCTION TEST; HIGH THROUGHPUT SCREENING; PHYSIOLOGY; PRECLINICAL STUDY; PROCEDURES; RAT; VALIDATION STUDY;

RATTUS;

ANIMALS; AUTOMATION; CARDIOTOXINS; CELLS, CULTURED; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MYOCYTES, CARDIAC; NIFEDIPINE; OPTOGENETICS; RATS;

EID: 84966359860     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms11542     Document Type: Article

References (42)

1. Reichert, J. M. Trends in development and approval times for new therapeutics in the United States. Nat. Rev. Drug Discov. 2, 695-702 (2003).
2. Preziosi, P. Science, pharmacoeconomics and ethics in drug R&D: A sustainable future scenario> Nat. Rev. Drug Discov. 3, 521-526 (2004).
3. FDA, U. S. Department of Health and Human Services. Challenge and opportunity on the critical path to new medical products. Rockville, MD: U. S. FDA (2004).
4. Piccini, J. P. et al. Current challenges in the evaluation of cardiac safety during drug development: Translational medicine meets the critical path initiative. Am. Heart J. 158, 317-326 (2009).
5. Fermini, B. et al. A new perspective in the field of cardiac safety testing through the comprehensive in vitro proarrhythmia assay paradigm. J. Biomol. Screen. 21, 1-11 (2015).
6. Bowlby, M. R., Peri, R., Zhang, H. & Dunlop, J. hERG (KCNH2 or Kv11. 1) K channels: screening for cardiac arrhythmia risk. Curr. Drug Metab. 9, 965-970 (2008).
7. Mirams, G. R. et al. Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk. Cardiovasc. Res. 91, 53-61 (2011).
8. Redfern, W. S. et al. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and Torsade de Pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc. Res. 58, 32-45 (2003).
9. Rodriguez, B. et al. The systems biology approach to drug development: Application to toxicity assessment of cardiac drugs. Clin. Pharmacol. Ther. 88, 130-134 (2010).
10. Bellin, M., Marchetto, M. C., Gage, F. H. & Mummery, C. L. Induced pluripotent stem cells: The new patient> Nat. Rev. Mol. Cell. Biol. 13, 713-726 (2012).
11. Khan, J. M., Lyon, A. R. & Harding, S. E. The case for induced pluripotent stem cell-derived cardiomyocytes in pharmacological screening. Br. J. Pharmacol. 169, 304-317 (2013).
12. Dunlop, J., Bowlby, M., Peri, R., Vasilyev, D. & Arias, R. High-throughput electrophysiology: An emerging paradigm for ion-channel screening and physiology. Nat. Rev. Drug Discov. 7, 358-368 (2008).
13. Fertig, N. & Farre, C. Renaissance of ion channel research and drug discovery by patch clamp automation. Future Med. Chem. 2, 691-695 (2010).
14. Moreno, J. D. et al. A computational model to predict the effects of class I antiarrhythmic drugs on ventricular rhythms. Sci Transl Med 3, 98ra83 (2011).
15. Ambrosi, C. M., Klimas, A., Yu, J. & Entcheva, E. Cardiac applications of optogenetics. Prog. Biophys. Mol. Biol. 115, 294-304 (2014).
16. Entcheva, E. Cardiac optogenetics. Am. J. Physiol. Heart Circ. Physiol. 304, H1179-H1191 (2013).
17. Hochbaum, D. R. et al. All-optical electrophysiology in mammalian neurons using engineered microbial rhodopsins. Nat. Methods 11, 825-833 (2014).
18. Nagel, G. et al. Channelrhodopsins: directly light-gated cation channels. Biochem. Soc. Trans. 33, 863-866 (2005).
19. Nagel, G. et al. Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc. Natl Acad. Sci. USA 100, 13940-13945 (2003).
20. Abilez, O. J. in Proceedings of Annual International Conference of the IEEE Engineering in Medicine and Biology Society 1386-1389 (San Diego, CA, USA, 2012).
21. Dugue, G. P., Akemann, W. & Knopfel, T. A comprehensive concept of optogenetics. Prog. Brain Res. 196, 1-28 (2012).
22. Leyton-Mange, J. S. et al. Rapid cellular phenotyping of human pluripotent stem cell-derived cardiomyocytes using a genetically encoded fluorescent voltage sensor. Stem Cell Rep. 2, 163-170 (2014).
23. Akemann, W., Lundby, A., Mutoh, H. & Knopfel, T. Effect of voltage sensitive fluorescent proteins on neuronal excitability. Biophys. J. 96, 3959-3976 (2009).
24. Burton, R. A. B. et al. Optical control of excitation waves in cardiac tissue. Nat. Photonics 9, 813-816 (2015).
25. Williams, J. C. et al. Computational optogenetics: empirically-derived voltageand light-sensitive channelrhodopsin-2 model. PLOS Comput. Biol. 9, e1003220 (2013).
26. Ambrosi, C. M. & Entcheva, E. Optogenetic control of cardiomyocytes via viral delivery. Methods Mol. Biol. 1181, 215-228 (2014).
27. Jia, Z. et al. Stimulating cardiac muscle by light: cardiac optogenetics by cell delivery. Circ Arrhythm Electrophysiol 4, 753-760 (2011).
28. Williams, J. C. & Entcheva, E. Optogenetic versus electrical stimulation of human cardiomyocytes: modeling insights. Biophys. J. 108, 1934-1945 (2015).
29. Ambrosi, C. M., Boyle, P. M., Chen, K., Trayanova, N. A. & Entcheva, E. Optogenetics-enabled assessment of viral gene and cell therapy for restoration of cardiac excitability. Sci. Rep. 5, 17350 (2015).
30. Johnson, D. M. et al. Diastolic spontaneous calcium release from the sarcoplasmic reticulum increases beat-to-beat variability of repolarization in canine ventricular myocytes after beta-adrenergic stimulation. Circ. Res. 112, 246-256 (2013).
31. Entcheva, E. & Bien, H. Macroscopic optical mapping of excitation in cardiac cell networks with ultra-high spatiotemporal resolution. Prog. Biophys. Mol. Biol. 92, 232-257 (2006).
32. Knollmann, B. C. Induced pluripotent stem cell-derived cardiomyocytes: boutique science or valuable arrhythmia model> Circ. Res. 112, 969-976 (2013).
33. Lu, Z. et al. Suppression of phosphoinositide 3-kinase signaling and alteration of multiple ion currents in drug-induced long QT syndrome. Sci. Transl. Med. 4, 131ra150 (2012).
34. Yang, T. et al. Screening for acute IKr block is insufficient to detect torsades de pointes liability: role of late sodium current. Circulation 130, 224-234 (2014).
35. Entcheva, E. & Bien, H. Acoustic micromachining of three-dimensional surfaces for biological applications. Lab Chip 5, 179-183 (2005).
36. Chung, C. Y. et al. Hypertrophic phenotype in cardiac cell assemblies solely by structural cues and ensuing self-organization. FASEB J. 25, 851-862 (2011).
37. Chung, C. Y., Bien, H. & Entcheva, E. The role of cardiac tissue alignment in modulating electrical function. J. Cardiovasc. Electrophysiol. 18, 1323-1329 (2007).
38. Zhang, F. et al. Multimodal fast optical interrogation of neural circuitry. Nature 446, 633-639 (2007).
39. Matiukas, A. et al. Near-infrared voltage-sensitive fluorescent dyes optimized for optical mapping in blood-perfused myocardium. Heart Rhythm 4, 1441-1451 (2007).
40. Entcheva, E. & Bien, H. Macroscopic optical mapping of excitation in cardiac cell networks with ultra-high spatiotemporal resolution. Prog. Biophys. Mol. Biol. 92, 232-257 (2006).
41. ten Tusscher, K. H. & Panfilov, A. V. Alternans and spiral breakup in a human ventricular tissue model. Am. J. Physiol. Heart Circ. Physiol. 291, H1088-H1100 (2006).
42. MacCannell, K. A. et al. A mathematical model of electrotonic interactions between ventricular myocytes and fibroblasts. Biophys. J. 92, 4121-4132 (2007).